ETF Holdings Breakdown of MRVI

News associated with MRVI

SG Americas Securities LLC Purchases 662,861 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

SG Americas Securities LLC lifted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 2,005.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 695,907 shares of the company’s stock after purchasing an additional 662,861 shares during the quarter. SG […] - 2025-06-16 07:54:59

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives $6.64 Average PT from Analysts

Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) have received an average recommendation of “Hold” from the twelve analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and four have issued a buy recommendation on […] - 2025-06-13 05:32:51

Stock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) saw unusually large options trading activity on Wednesday. Stock traders bought 1,002 put options on the company. This represents an increase of 1,791% compared to the average daily volume of 53 put options. Maravai LifeSciences Trading Up 5.6% Shares of MRVI opened at $2.28 on Thursday. […] - 2025-06-12 07:44:46

Traders Purchase High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) saw unusually large options trading activity on Wednesday. Traders bought 1,002 put options on the company. This represents an increase of 1,791% compared to the typical volume of 53 put options. Hedge Funds Weigh In On Maravai LifeSciences A number of hedge funds have recently added […] - 2025-05-30 08:39:03

Ameriprise Financial Inc. Raises Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Ameriprise Financial Inc. lifted its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 1.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,611,625 shares of the company’s stock after purchasing an additional 62,123 shares during the quarter. Ameriprise Financial Inc. owned […] - 2025-05-16 08:03:26

Price T Rowe Associates Inc. MD Acquires 7,946 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Price T Rowe Associates Inc. MD lifted its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 12.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 70,828 shares of the company’s stock after purchasing an additional 7,946 shares during the […] - 2025-05-15 08:20:51

Dimensional Fund Advisors LP Increases Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Dimensional Fund Advisors LP grew its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 20.4% during the fourth quarter, Holdings Channel reports. The firm owned 1,311,700 shares of the company’s stock after purchasing an additional 221,908 shares during the period. Dimensional Fund Advisors LP’s holdings in Maravai LifeSciences were worth […] - 2025-05-12 07:47:02

Envestnet Asset Management Inc. Has $104,000 Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Envestnet Asset Management Inc. lowered its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 55.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 19,016 shares of the company’s stock after selling 23,677 shares during the period. Envestnet Asset Management Inc.’s holdings in Maravai LifeSciences were worth $104,000 as […] - 2025-05-09 07:22:43

Barclays PLC Purchases 23,103 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Barclays PLC boosted its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 12.5% in the fourth quarter, Holdings Channel reports. The fund owned 207,292 shares of the company’s stock after purchasing an additional 23,103 shares during the quarter. Barclays PLC’s holdings in Maravai LifeSciences were worth $1,129,000 as of its […] - 2025-05-05 07:48:49

Stock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 1,002 put options on the stock. This is an increase of 1,791% compared to the typical volume of 53 put options. Wall Street Analysts Forecast Growth A number of research firms recently weighed in […] - 2025-05-01 07:47:03

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives $6.34 Consensus PT from Analysts

Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) have earned a consensus recommendation of “Hold” from the eleven brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have issued a buy recommendation on the […] - 2025-04-24 05:28:50

Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Investors purchased 1,002 put options on the company. This represents an increase of approximately 1,791% compared to the average volume of 53 put options. Maravai LifeSciences Stock Performance NASDAQ MRVI opened at $1.72 on Thursday. […] - 2025-04-17 07:40:59

JPMorgan Chase & Co. Purchases 200,411 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

JPMorgan Chase & Co. grew its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 4.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,250,656 shares of the company’s stock after acquiring an additional 200,411 shares during the period. JPMorgan Chase & Co.’s […] - 2025-04-10 08:07:14

Orion Portfolio Solutions LLC Sells 39,057 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Orion Portfolio Solutions LLC decreased its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 28.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 96,692 shares of the company’s stock after selling 39,057 shares during the period. Orion Portfolio Solutions LLC’s holdings in Maravai LifeSciences […] - 2025-04-08 07:58:52

Mitsubishi UFJ Asset Management Co. Ltd. Grows Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 118.5% in the fourth quarter, HoldingsChannel reports. The firm owned 52,508 shares of the company’s stock after buying an additional 28,480 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Maravai LifeSciences were […] - 2025-04-04 08:12:56

10,336 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Purchased by Cibc World Markets Corp

Cibc World Markets Corp purchased a new stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 10,336 shares of the company’s stock, valued at approximately $56,000. A number of other institutional investors and hedge funds […] - 2025-03-28 08:18:49

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of “Hold” by Brokerages

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) has earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and four have given a buy recommendation to the […] - 2025-03-27 06:38:49

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Short Interest Update

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of a large decline in short interest in February. As of February 28th, there was short interest totalling 8,820,000 shares, a decline of 14.4% from the February 13th total of 10,300,000 shares. Based on an average daily volume of 2,640,000 shares, the short-interest […] - 2025-03-21 07:10:51

Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading on Wednesday. Traders acquired 1,002 put options on the stock. This represents an increase of approximately 1,791% compared to the typical volume of 53 put options. Insider Transactions at Maravai LifeSciences In other news, General Counsel Kurt Oreshack […] - 2025-03-20 08:14:54

Rhumbline Advisers Has $1.01 Million Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Rhumbline Advisers raised its stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 9.9% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 185,221 shares of the company’s stock after buying an additional 16,712 shares during the period. Rhumbline Advisers’ holdings in Maravai LifeSciences were worth $1,009,000 at the end of the […] - 2025-03-07 08:22:56

Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 1,002 put options on the stock. This represents an increase of 1,791% compared to the typical daily volume of 53 put options. Insider Activity at Maravai LifeSciences In related news, General Counsel Kurt Oreshack […] - 2025-03-06 07:03:00

Maravai LifeSciences (NASDAQ:MRVI) Hits New 12-Month Low Following Analyst Downgrade

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report)’s share price hit a new 52-week low on Tuesday after Bank of America lowered their price target on the stock from $9.00 to $8.00. Bank of America currently has a buy rating on the stock. Maravai LifeSciences traded as low as $2.92 and last traded at […] - 2025-03-06 06:29:07

Maravai LifeSciences (NASDAQ:MRVI) Shares Down 6.7% on Analyst Downgrade

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report)’s share price was down 6.7% during trading on Monday after Bank of America lowered their price target on the stock from $9.00 to $8.00. Bank of America currently has a buy rating on the stock. Maravai LifeSciences traded as low as $3.01 and last traded at […] - 2025-03-05 06:53:09

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives $9.46 Consensus Price Target from Brokerages

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) has been assigned an average recommendation of “Hold” from the twelve brokerages that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the […] - 2025-03-05 06:20:49

Bleakley Financial Group LLC Has $227,000 Stock Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Bleakley Financial Group LLC lifted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 30.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 41,691 shares of the company’s stock after acquiring an additional 9,657 shares during the period. Bleakley Financial Group LLC’s holdings in Maravai LifeSciences were worth $227,000 as of […] - 2025-02-13 08:46:56

Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,002 put options on the company. This represents an increase of approximately 1,791% compared to the average volume of 53 put options. Analyst Ratings Changes MRVI has been the subject of a […] - 2025-02-06 07:14:57

China Universal Asset Management Co. Ltd. Has $164,000 Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

China Universal Asset Management Co. Ltd. boosted its stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 10.5% in the fourth quarter, HoldingsChannel reports. The firm owned 30,076 shares of the company’s stock after buying an additional 2,851 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Maravai LifeSciences were […] - 2025-02-04 09:14:53

MRVI institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-29	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	77,252	USD 183,087 6.8%
2025-05-29	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	11,671	USD 27,660 6.7%
2025-06-26	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	134,748	USD 320,700
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	74,479	USD 177,260
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	74,479	USD 177,260
2025-05-29	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	456	USD 1,081 6.8%
Total =		373,085	USD 887,048

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer